BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33154671)

  • 1. Diameter of Superior Rectal Vein - CT Predictor of KRAS Mutation in Rectal Carcinoma.
    Song C; Shen B; Dong Z; Fan Z; Xu L; Li ZP; Li Y; Feng ST
    Cancer Manag Res; 2020; 12():10919-10928. PubMed ID: 33154671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative Evaluation of the Value of Quantitative Parameters of Dual-energy CT and MRI for KRAS Mutation in Rectal Cancer].
    Lin XQ; Han T; Jing MY; Deng LN; Zhang B; Zhou JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Aug; 44(4):606-613. PubMed ID: 36065693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRAS mutation status between left- and right-sided colorectal cancer: are there any differences in computed tomography?
    Yu MM; Shi D; Li Q; Li JB; Li Q; Yu RS
    Jpn J Radiol; 2023 Jan; 41(1):83-91. PubMed ID: 35976561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Extramural Venous Invasion by Diffusion-Weighted Magnetic Resonance Imaging and Computed Tomography in Rectal Adenocarcinoma.
    Gursoy Coruh A; Peker E; Elhan A; Erden I; Erden A
    Can Assoc Radiol J; 2019 Nov; 70(4):457-465. PubMed ID: 31582328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of lymphovascular invasion in rectal cancer by preoperative CT.
    Wu CC; Lee RC; Chang CY
    AJR Am J Roentgenol; 2013 Nov; 201(5):985-92. PubMed ID: 24147468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of inferior mesenteric vessel and ureter by contrast-enhanced abdominal pelvic CT and its clinical influence on laparoscopic rectal surgery].
    Zuo S; Wang K; Li JH; An H; Guo XC; Wang X
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):294-299. PubMed ID: 32192310
    [No Abstract]   [Full Text] [Related]  

  • 8. Could IVIM and ADC help in predicting the KRAS status in patients with rectal cancer?
    Xu Y; Xu Q; Sun H; Liu T; Shi K; Wang W
    Eur Radiol; 2018 Jul; 28(7):3059-3065. PubMed ID: 29450716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT Texture Analysis: A Potential Biomarker for Evaluating KRAS Mutational Status in Colorectal Cancer.
    Cao J; Wang GR; Wang ZW; Jin ZY
    Chin Med Sci J; 2020 Dec; 35(4):306-314. PubMed ID: 33413746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizing MRI features of rectal cancers with different KRAS status.
    Xu Y; Xu Q; Ma Y; Duan J; Zhang H; Liu T; Li L; Sun H; Shi K; Xie S; Wang W
    BMC Cancer; 2019 Nov; 19(1):1111. PubMed ID: 31727020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU; Won KS; Song BI; Jeong WK; Baek SK; Kim HW
    Cancer Imaging; 2018 Sep; 18(1):32. PubMed ID: 30217167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rectal cancer: can T2WI histogram of the primary tumor help predict the existence of lymph node metastasis?
    Yang L; Liu D; Fang X; Wang Z; Xing Y; Ma L; Wu B
    Eur Radiol; 2019 Dec; 29(12):6469-6476. PubMed ID: 31278581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS mutation status concordance between the primary tumor and the corresponding metastasis in patients with rectal cancer.
    Jo P; Bernhardt M; Nietert M; König A; Azizian A; Schirmer MA; Grade M; Kitz J; Reuter-Jessen K; Ghadimi M; Ströbel P; Schildhaus HU; Gaedcke J
    PLoS One; 2020; 15(10):e0239806. PubMed ID: 33002027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of MRI Radiomics for Predicting KRAS Mutation in Rectal Cancer.
    Guo XF; Yang WQ; Yang Q; Yuan ZL; Liu YL; Niu XH; Xu HB
    Curr Med Sci; 2020 Dec; 40(6):1156-1160. PubMed ID: 33428144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Value of
    Arslan E; Aksoy T; Gürsu RU; Dursun N; Çakar E; Çermik TF
    Mol Imaging Radionucl Ther; 2020 Feb; 29(1):17-24. PubMed ID: 32079384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between oncogenic RAS mutation and radiologic-pathologic findings in patients with primary rectal cancer.
    Jo SJ; Kim SH
    Quant Imaging Med Surg; 2019 Feb; 9(2):238-246. PubMed ID: 30976548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatoid adenocarcinoma of the stomach: CT findings.
    Yang Q; Liu Y; Zhang S
    Front Oncol; 2023; 13():1036763. PubMed ID: 36816961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of lateral lymph node metastasis for advanced low rectal cancer.
    Wu ZY; Wan J; Li JH; Zhao G; Yao Y; Du JL; Liu QF; Peng L; Wang ZD; Huang ZM; Lin HH
    World J Gastroenterol; 2007 Dec; 13(45):6048-52. PubMed ID: 18023098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis on CT in diagnosis of lymph node metastasis of thoracic esophageal cancer with minimum diameter greater than 1 cm].
    Wu HR; Liu CQ; Guo MF; Xu MQ; Mei XY
    Zhonghua Wai Ke Za Zhi; 2019 Aug; 57(8):601-606. PubMed ID: 31422630
    [No Abstract]   [Full Text] [Related]  

  • 20. The value of
    Oner AO; Budak ES; Yıldırım S; Aydın F; Sezer C
    Hell J Nucl Med; 2017; 20(2):160-165. PubMed ID: 28697193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.